Asston Pharmaceuticals Stock: price and insider trades · India
IN·Mcap ₹1.1B
1 insider bought shares over the last 90 days, the latest by Prakruti R Pali, filed 23 Sept 2026.
Asston Pharmaceuticals: what insiders have been doing
Only a handful of insider records exist for Asston Pharmaceuticals, the last one from 23 September 2026, too few to describe a trend. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySalePrakruti R Pali1 buy
Fundamental score
Ranked 15,728 of 26,911 companies
46.5
score / 100
Value24
Quality69
FCF yld-12%
Earn yld2.4%
EV/EBITDA30.5x
ROE15%
Gross mgn32%
Net mgn15%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹102.41
Analyst consensus
Income statement
Revenue₹254.7M
Gross profit₹80.6M32% margin
EBITDA₹55.3M22% margin
Net income₹38.7M15.2% margin
Valuation
PER (trailing)21.8x
P/Book2.2x
Balance sheet & cash
Market cap₹1.1B
Total debt₹51.1M
Free Cash Flow-₹202.4M
Debt / Equity13%
Profitability & ownership
ROE15.5%
ROA-1.3%
% insiders53.4%
% institutions0.0%
Last declaration on 23 September 2026
Declarations1 total
- 240,000 shares-MarketSEBI:1aabd9d22adacfbf5a266c1b815c6557ae13a2daCanonical exit: 22 Dec 2026 (T+90)
1 of 1 declaration
About Asston Pharmaceuticals
Asston Pharmaceuticals is a company focused on the development and marketing of pharmaceuticals. It is listed on the XBOM.